Ms. Troe is an experienced public company independent director. She serves on the Board of Directors of Rubicon Project, Inc., an NYSE-listed technology company, and is an “audit committee financial expert”, Chair of the Audit Committee and a Member of the Nominating and Governance Committee (since February 2014). Ms. Troe serves on the Board of Directors of TheraCann International Benchmark Corp, expected to be listed on a Canadian stock exchange in mid-2019; she is Chair of the Audit Committee and a Member of the Nominating and Governance Committee (since December 2018). Ms. Troe has served on the Boards of Directors of three private companies and is actively seeking to serve on an additional public company board.
Ms. Troe brings strong accounting/financial expertise with an extensive background in public company governance and oversight, enterprise risk management, financial investigations and securities litigation. She has worked with boards, committees of boards, executives, and their counsel in complex, crisis driven, mission critical situations to address high level strategic issues that affect the enterprise, C-suite executives, shareholders and other stakeholders. She qualifies as an “audit committee financial expert”.
She is a CPA and a member of the American Institute of Certified Public Accountants. Ms. Troe is a credentialed NACD Governance Fellow and a member of the National Association of Corporate Directors. She has completed the NACD Cyber-Risk Oversight Program and holds a CERT Certificate in Cybersecurity Oversight issued by the Software Engineering Institute of Carnegie Mellon University. She is a member of Women Corporate Directors and Association of Securities and Exchange Commission Alumni, and is an associate member of the American Bar Association.
Mr. Troe has served on the boards of numerous private companies in diverse businesses, including medical devices, biotechnology, high temperature materials, flat panel display technology, financial services, mining, and oil and gas exploration and production. For many years he served on the boards of the Life Science Industry Council and the Southern California Biomedical Council (not for profit corporations). He served for six years as a director of the Los Angeles Biomedical Research Institute, including five years as chair of the Audit Committee. As Audit Committee Chair of LA Biomed, he wrote the Audit Committee Charter and organized and supervised an investigation of senior officer misconduct in contract administration that resulted in presentation of a formal report to the Board of Directors and dismissal of the officer.
See Mr. Troe’s Experience for further information.